Risks associated with nano MBBT
By the AVICENN team – Last updated November 2020
Risks associated with nano MBBT
MBBT is insoluble and persistent / bioaccumulative.
In its opinions published in 2013 and 20151See :
– Opinion on 2,2′-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol), Scientific Committee on Consumer Safety (SCCS / CSSC), COLIPA No. S79, SCCS/1460/11, March 2013 (revised July 2013)
– Opinion on 2,2′-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano form), Submission III, SCCS, SCCS/1546/15, March 2015 (publication June 2015)., the European Scientific Committee on Consumer Safety (SCCS) supported the use of an uncoated form of MBBT as a UV filter in dermally applied products, mainly on the basis of a lack of dermal absorption as insoluble particles.
It has been permitted since 2018 at a concentration of 10% m/m, except for applications that may result in end-user lung exposure through inhalation of this substance.
However, due to the inflammatory effects by inhalation as well as a lack of clarity with respect to the potential genotoxicity/carcinogenicity and because some applications listed in the European catalog of nanomaterials used in cosmetics can lead to oral or inhalation exposure, MBBT nano was ranked as the highest risk nanomaterial in the cosmetic sector by the SCCS in October 20202Cf. Scientific advice on the safety of nanomaterials in cosmetics – Preliminary advice, Scientific Committee on Consumer Safety (SCCS / SCCS), 5 October 2020: Priority for Risk Potential (according to Brand et al., 2019): 34.
Any questions or comments? This information sheet compiled by AVICENN is intended to be completed and updated. Please feel free to contribute.
Other news on the topic
Upcoming Nano Agenda
- Webinar presenting the example guide produced by NanoMesureFrance, to illustrate the difficulties encountered in dimensional analysis of particles by electron and atomic force microscopy.
- Organizers: Association NanoMesureFrance
- Speakers: Valérie Godefert & François-Xavier Ouf (LNE & NanoMesureFrance)
- Website: www.eventbrite.fr/…nanomesurefrance-webinar-…
- Advanced Characterization Techniques in Nanomaterials and Nanotechnology
- 10th European Congress on Advanced Nanotechnology and Nanomaterials
- 14 and 15 April 2025
- Website: https://nanomaterialsconference.com
- 5th Joint Symposium on Nanotechnology
- Organizers: the Fraunhofer Nanotechnology Network, with the support of the Federal Institute for Risk Assessment (BfR)
- Date: May 13-14, 2025
- Topics:
- the application of nanotechnology in various sectors, including digitalization, 2D/3D printing, carbon-based materials and battery materials
- nano on various regulations (REACh, food contact materials, cosmetics, bioagents, PPPs)
- adaptation and development of OECD Test Guidelines for nano and advanced materials (Malta Initiative)
- review on nano-specific NAMs (new approach methodologies)
- when you’re nano and you know it: dealing with uncertainty regarding the nanomaterial definition in regulatory frameworks
- …
- Website: www.isc.fraunhofer.de/…2025/5th-symposium-nanotechnology.html
File initially created in November 2020
Notes and references
- 1See :
– Opinion on 2,2′-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol), Scientific Committee on Consumer Safety (SCCS / CSSC), COLIPA No. S79, SCCS/1460/11, March 2013 (revised July 2013)
– Opinion on 2,2′-Methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano form), Submission III, SCCS, SCCS/1546/15, March 2015 (publication June 2015). - 2Cf. Scientific advice on the safety of nanomaterials in cosmetics – Preliminary advice, Scientific Committee on Consumer Safety (SCCS / SCCS), 5 October 2020: Priority for Risk Potential (according to Brand et al., 2019): 34